UY34475A - Nueva asociación entre la 4-{3-[cis-hexahidrociclopenta[c]pirrol-2(1h)-il] propoxi}benzamida y un antagonista de los receptores nmda y las composiciones farmacéuticas que la contienen - Google Patents

Nueva asociación entre la 4-{3-[cis-hexahidrociclopenta[c]pirrol-2(1h)-il] propoxi}benzamida y un antagonista de los receptores nmda y las composiciones farmacéuticas que la contienen

Info

Publication number
UY34475A
UY34475A UY0001034475A UY34475A UY34475A UY 34475 A UY34475 A UY 34475A UY 0001034475 A UY0001034475 A UY 0001034475A UY 34475 A UY34475 A UY 34475A UY 34475 A UY34475 A UY 34475A
Authority
UY
Uruguay
Prior art keywords
hexahydrociclopenta
propoxi
benzamida
pirrol
antagonist
Prior art date
Application number
UY0001034475A
Other languages
English (en)
Inventor
Merdes Annette
Sors Aurore
Caryn Trocme-Thibierge
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47682151&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY34475(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of UY34475A publication Critical patent/UY34475A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Asociación entre la 4-{3-[cis-hexahidrociclopenta[c]pirrol-2(1H)-il]propoxi}benzamida de fórmula (I): o una de sus sales de adición a un ácido o a una base farmacéuticamente aceptable, y un antagonista de los receptores glutamatérgicos NMDA. Medicamentos.
UY0001034475A 2011-12-09 2012-11-28 Nueva asociación entre la 4-{3-[cis-hexahidrociclopenta[c]pirrol-2(1h)-il] propoxi}benzamida y un antagonista de los receptores nmda y las composiciones farmacéuticas que la contienen UY34475A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161568831P 2011-12-09 2011-12-09
FR1103777A FR2983732B1 (fr) 2011-12-09 2011-12-09 Nouvelle association entre le 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
UY34475A true UY34475A (es) 2013-07-31

Family

ID=47682151

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034475A UY34475A (es) 2011-12-09 2012-11-28 Nueva asociación entre la 4-{3-[cis-hexahidrociclopenta[c]pirrol-2(1h)-il] propoxi}benzamida y un antagonista de los receptores nmda y las composiciones farmacéuticas que la contienen

Country Status (27)

Country Link
US (2) US8921409B2 (es)
EP (1) EP2601942A1 (es)
JP (1) JP5591310B2 (es)
KR (1) KR101489670B1 (es)
CN (1) CN103157111B (es)
AP (1) AP3225A (es)
AR (1) AR089112A1 (es)
AU (1) AU2012258339A1 (es)
BR (1) BR102012031031A2 (es)
CA (1) CA2798549A1 (es)
CL (1) CL2012003437A1 (es)
CO (2) CO6660080A1 (es)
CR (1) CR20120608A (es)
EA (1) EA201201530A1 (es)
EC (1) ECSP12012329A (es)
FR (1) FR2983732B1 (es)
GT (1) GT201200329A (es)
MA (1) MA34867B1 (es)
MD (1) MD4348B1 (es)
MX (1) MX2012014184A (es)
NI (1) NI201200178A (es)
PE (1) PE20130813A1 (es)
SG (1) SG191494A1 (es)
TN (1) TN2012000563A1 (es)
TW (1) TWI457123B (es)
UY (1) UY34475A (es)
WO (1) WO2013083887A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3003466B1 (fr) * 2013-03-22 2015-08-07 Servier Lab Utilisation du 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide pour le traitement des douleurs neuropathiques
KR101484405B1 (ko) * 2013-08-14 2015-01-19 서울대학교산학협력단 Ｎｉｎｊｕｒｉｎ１ 결핍 유래의 강박증 예방 또는 치료용 약학적 조성물
GB201509134D0 (en) * 2015-05-28 2015-07-15 Electrophoretics Ltd Biomolecules involved in Alzheimer's disease
CA2986345A1 (en) * 2015-07-22 2017-01-26 Anavex Life Sciences Corp. Enantiomers of tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanmethanamine (anavex2-73) and use thereof in the treatment of alzheimer's disease and other disorders modulated by the sigma 1 receptor

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003101458A1 (en) * 2002-05-31 2003-12-11 H. Lundbeck A/S A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease
WO2005000216A2 (en) * 2003-05-27 2005-01-06 Forest Laboratories, Inc. Combination of an nmda receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders
US7432280B2 (en) * 2003-06-20 2008-10-07 Eli Lilly And Company 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake
DE602005024511D1 (de) * 2004-01-05 2010-12-16 Merz Pharma Gmbh & Co Kgaa Memantin für die behandlung von leichtem bis mittelschwerem morbus alzheimer
FR2866647B1 (fr) * 2004-02-20 2006-10-27 Servier Lab Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TW200531680A (en) * 2004-03-03 2005-10-01 Merz Pharma Gmbh & Co Kgaa Therapy using 1-aminocyclohexane derivatives for the treatment of behavioral disorders associated with alzheimer's disease
EP1740172A4 (en) * 2004-03-19 2007-10-10 Axonyx Inc ACETYLCHOLINESTERASE INHIBITORS AND N-METHYL-D-ASPARTATE ANTAGONISTS FOR THE TREATMENT OF COGNITIVE DISORDER
FR2937119B1 (fr) 2008-10-15 2010-12-17 Air Liquide Procede de production d'energie et capture de co2
FR2937251B1 (fr) * 2008-10-16 2011-03-18 Servier Lab Utilisation du 4-{3-°hexahydrocyclopenta°c!pyrrol-2(1h)-yl! propoxy}benzamide pour l'obtention de medicaments destines au traitement des troubles du sommeil
FR2953515B1 (fr) * 2009-12-09 2011-12-23 Servier Lab Nouveaux derives du type hexahydrocyclopenta[b]pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
TN2012000563A1 (fr) 2014-04-01
AP3225A (en) 2015-04-30
TWI457123B (zh) 2014-10-21
CN103157111A (zh) 2013-06-19
AU2012258339A1 (en) 2013-06-27
WO2013083887A8 (fr) 2013-08-08
CL2012003437A1 (es) 2014-01-24
AR089112A1 (es) 2014-07-30
CN103157111B (zh) 2015-02-11
FR2983732A1 (fr) 2013-06-14
US20130150421A1 (en) 2013-06-13
CA2798549A1 (fr) 2013-06-09
EA201201530A1 (ru) 2013-07-30
US8921409B2 (en) 2014-12-30
EP2601942A1 (fr) 2013-06-12
BR102012031031A2 (pt) 2013-10-29
FR2983732B1 (fr) 2013-11-22
MD4348B1 (ro) 2015-05-31
KR20130065602A (ko) 2013-06-19
GT201200329A (es) 2014-03-14
PE20130813A1 (es) 2013-07-28
CO6690116A1 (es) 2013-06-17
MX2012014184A (es) 2013-06-18
AP2012006607A0 (en) 2012-12-31
MA34867B1 (fr) 2014-02-01
US20150080448A1 (en) 2015-03-19
JP5591310B2 (ja) 2014-09-17
WO2013083887A1 (fr) 2013-06-13
TW201334777A (zh) 2013-09-01
NI201200178A (es) 2013-05-13
CR20120608A (es) 2014-03-05
KR101489670B1 (ko) 2015-02-04
NZ604084A (en) 2014-07-25
ECSP12012329A (es) 2013-01-31
SG191494A1 (en) 2013-07-31
CO6660080A1 (es) 2013-04-30
JP2013121956A (ja) 2013-06-20

Similar Documents

Publication Publication Date Title
CO2017002532A2 (es) Indazoles sustituidos con bencilo como inhibidores de bub1
CL2017000969A1 (es) Composiciones del factor viii y métodos para hacerlas y usarlas (divisional solicitud no. 2166-2014)
CR20140106A (es) Compuestos y composiciones como inhibidores de la quinasa c-kit
UY34502A (es) Arilos y heteroarilos bicíclicos inhibidores de los canales de sodio
ECSP13013074A (es) Nuevos derivados de piridina
UY34550A (es) Bencilpirazoles sustituidos
UY33958A (es) Inhibidores de la glucosilceramida sintasa
UY34111A (es) Nuevos co-cristales de agomelatina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
UY33930A (es) Inhibidores novedosos de quinasas
UY33883A (es) Novedosos derivados heterocíclicos
UY34365A (es) Compuestos heterociclicos
UY34572A (es) Compuestos heterocíclicos agonistas del receptor ip
CO7091177A2 (es) Inhibidores de la beta-secretasa
UY34221A (es) Quinolinas sustituidas inhibidoras de la proteina syk quinasa y su uso como medicamentos
UY34800A (es) Combinaciones farmacéuticas que contienen un inhibidor de 11-beta-hidroxiesteroide dehidrogenasa-1 útil en trastornos metabólicos
UY34212A (es) Derivados de piridin-2(1h)-ona como inhibidores de jak
CR20150204A (es) Nuevos derivados de piridina
UY34197A (es) NUEVOS ANTAGONISTAS DE CRTh2
UY34198A (es) NUEVOS ANTAGONISTAS DE CRTh2
UY33957A (es) Moduladores de los receptores de hormonas nucleares
UY34193A (es) Aparato para medir un objeto
UY34482A (es) Composiciones y métodos para mejorar la calidad de los espermatozoides procesados
UY34050A (es) Nueva asociación entre la 4-{3-[cis-hexahidrociclopenta[c]pirrol- 2(1h)-il]propoxi}benzamida y un inhibidor de la acetilcolinesterasa y las composiciones farmacéuticas que la contienen
CR20150210A (es) Nuevos derivados de pirazina como agonistas receptores de cb2
UY34115A (es) Ensayo de la lisil oxidasa-like 2 y sus métodos de empleo